84 results
8-K
EX-2.2
ORTX
Orchard Therapeutics plc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
successor Rights Agent who shall be a stock transfer agent of national reputation in the US or the corporate trust department of an international … . or the corporate trust department of an international commercial bank.
(e) The Rights Agent will cooperate with Purchaser and any successor Rights Agent
DEFA14A
ORTX
Orchard Therapeutics plc
8 Dec 23
Additional proxy soliciting materials
4:39pm
or by contacting Orchard’s Investor Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain of its directors
8-K
ORTX
Orchard Therapeutics plc
8 Dec 23
Other Events
4:37pm
at ir.orchard-tx.com or by contacting Orchard’s Investor Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain
DEFA14A
ORTX
Orchard Therapeutics plc
30 Nov 23
Additional proxy soliciting materials
4:13pm
Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain of its directors and executive officers may
8-K
ORTX
Orchard Therapeutics plc
30 Nov 23
Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
4:06pm
at ir.orchard-tx.com or by contacting Orchard’s Investor Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain
DEFA14A
i3pjibvkl5y
21 Nov 23
Additional proxy soliciting materials
7:53am
8-K
h048b ttxnfox
21 Nov 23
Other Events
7:51am
DEFM14A
e95fnth
16 Nov 23
Proxy related to merger
4:45pm
8-K
r3j8hu8r5cdc
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
8-K
EX-99.1
91o42ha28fcr4mjo5
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
PREM14A
2l7l8xpp cvquu61
3 Nov 23
Preliminary proxy related to merger
5:11pm
DEFA14A
qg3nv7zn0vix
17 Oct 23
Additional proxy soliciting materials
4:32pm
DEFA14C
hnmwdb1m3ubso6888x
5 Oct 23
Additional information
5:26pm
DEFA14C
115q exfd7p9gfyda
5 Oct 23
Additional information
4:48pm
DEFA14C
px2bh
5 Oct 23
Additional information
4:45pm
DEFA14C
gdhztr0jttbb05ljw1
5 Oct 23
Additional information
4:43pm
DEFA14C
4txz2ic oqk52clwk1
5 Oct 23
Additional information
4:40pm
DEFA14A
xhc9kvb5vx ot5y69
5 Oct 23
Additional proxy soliciting materials
9:07am
8-K
EX-99.1
jefb1 bxl
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am